Supplemental material
Open access
1,780
Views
6
CrossRef citations to date
0
Altmetric
Oncology
Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States
Jinan Liua Value, Evidence, and Outcomes, GSK, Collegeville, PA, USACorrespondence[email protected]
, Bruno Emondb Analysis Group, Montreal, Quebec, Canada
, Eric M. Maiesec Value, Evidence, and Outcomes, GlaxoSmithKline, Navy Yard, PA, USA
, Marie-Hélène Lafeuilleb Analysis Group, Montreal, Quebec, Canada
, Patrick Lefebvreb Analysis Group, Montreal, Quebec, Canada
, Isabelle Ghelerterb Analysis Group, Montreal, Quebec, Canada
, Caterina Wud Analysis Group, Menlo Park, CA, USA
, Jean A. Hurteaue US Medical Affairs, Women’s Oncology Portfolio, GSK, Waltham, MA, USA
& Premal H. Thakerf Department of Gynecologic Oncology, Washington University School of Medicine, St. Louis, MO, USA
show all
Pages 1935-1945
|
Received 21 Jan 2022, Accepted 09 Aug 2022, Published online: 27 Aug 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.